Atta-ur-Rahman School of Applied Biosciences, NUST, Islamabad, Pakistan.
Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan.
Lipids Health Dis. 2020 Mar 16;19(1):46. doi: 10.1186/s12944-020-01231-9.
Myrin®-p Forte is an anti-tuberclosis agent that can cause hepatic injuries in clinical settings. Maytenus royleanus (Celastraceae) is a medicinal plant, possesses antioxidant and anticancer activities. The hepatoprotective effect of the methanol extract of Maytenus royleanus leaves (MEM) against Myrin®-p Forte induced hepatotoxicity in mice was investigated.
Mice were randomly parted into six groups (n = 6). Fixed-dose combination of Myrin®-p Forte (13.5 mg/kg Rifampicin, 6.75 mg/kg Isoniazid, 36.0 mg/kg Pyrazinamide and 24.8 mg/kg Ethambutol; RIPE] was administered for 15 days to induce liver injury. In treatment groups MEM (200 mg/kg and 400 mg/kg doses) and Vitamin B6 (180mg/kg) were administered prior to RIPE. Control group received 2% DMSO. Serum liver function tests, DNA damage, tissue antioxidant enzymes and histopathological alterations were studied. HPLC analysis was performed to determine the chemical composition using standard compounds.
The quercitin, gallic acid, luteolin, viteixin, apigenin, kaempherol, hyperoside and myricetin contents of all samples were determined by reverse-phase HPLC. Quercetin (0.217 mg/g dry weight) and luteolin (0.141 mg/g dry weight) were the major flavonoids identified in MEM. Myrin®-p Forte markedly (p < 0.05) deteriorated lipid profile and upregulated the concentration of LDH, AST, ALP, ALT and γ-GT in serum along with DNA fragmentation (37.13 ± 0.47%) and histopathological injuries in hepatic tissues of mice compared with the control group. Myrin®-p Forte increased (p < 0.001) lipid peroxidation and HO while decreased (p < 0.001) the activity level of CAT, SOD, POD, GPx, GST, GSR, γ-GT and GSH. Co-administration of MEM (200 mg/kg; 400 mg/kg) or the vitamin B6 (180 mg/kg) to Myrin®-p Forte administered mice significantly ameliorated LDL, cholesterol, HDL and triglyceride content. Furthermore, MEM dose dependently corrected serum liver function tests, decrease % DNA fragmentation (17.82 ± 0.35 and 7.21 ± 0.32 respectively), DNA damage. MEM treated protect RIPE induced oxidative damage by enhancing antioxidants to oxidants balance. Histological examination comprehends biochemical findings.
The antioxidant effects of MEM exerted the hepatoprotective potential against the Myrin®-p Forte induced hepatotoxicity in mice.
Myrin®-p Forte 是一种抗结核药物,在临床环境中会导致肝损伤。卫矛科植物短梗南蛇藤(Celastraceae)是一种药用植物,具有抗氧化和抗癌活性。本研究旨在探讨短梗南蛇藤叶甲醇提取物(MEM)对 Mynin®-p Forte 诱导的小鼠肝毒性的保护作用。
将小鼠随机分为六组(每组 n = 6)。固定剂量的 Mynin®-p Forte(利福平 13.5mg/kg、异烟肼 6.75mg/kg、吡嗪酰胺 36.0mg/kg 和乙胺丁醇 24.8mg/kg)[RIPE]给药 15 天诱导肝损伤。在治疗组中,MEM(200mg/kg 和 400mg/kg 剂量)和维生素 B6(180mg/kg)在 RIPE 之前给药。对照组给予 2% DMSO。研究了血清肝功能试验、DNA 损伤、组织抗氧化酶和组织病理学改变。采用高效液相色谱法(HPLC)分析,使用标准化合物确定化学成分。
通过反相高效液相色谱法(RP-HPLC)测定了所有样品中槲皮素、没食子酸、木樨草素、维替宁、芹菜素、山奈酚、高圣草苷、杨梅素和杨梅素的含量。MEM 中主要的黄酮类化合物为槲皮素(0.217mg/g 干重)和木樨草素(0.141mg/g 干重)。与对照组相比,Mynin®-p Forte 显著(p<0.05)恶化了血脂谱,并上调了血清中 LDH、AST、ALP、ALT 和γ-GT 的浓度,以及 DNA 片段化(37.13±0.47%)和肝组织的组织病理学损伤。与对照组相比,Mynin®-p Forte 增加(p<0.001)了脂质过氧化和 HO,同时降低(p<0.001)了 CAT、SOD、POD、GPx、GST、GSR、γ-GT 和 GSH 的活性水平。MEM(200mg/kg;400mg/kg)或维生素 B6(180mg/kg)与 Mynin®-p Forte 联合给药显著改善了 LDL、胆固醇、HDL 和甘油三酯含量。此外,MEM 剂量依赖性地纠正了血清肝功能试验,降低了%DNA 片段化(分别为 17.82±0.35 和 7.21±0.32)和 DNA 损伤。MEM 治疗通过增强抗氧化剂与氧化剂的平衡来保护 RIPE 诱导的氧化损伤。组织学检查包括生化发现。
MEM 的抗氧化作用发挥了对 Mynin®-p Forte 诱导的小鼠肝毒性的保护作用。